Study of human immunodeficiency virus and HCV infections in intravenous drug users in Mumbai

Saraswathi, K.; Dutta, A.
April 2007
Indian Journal of Medical Microbiology;Apr2007, Vol. 25 Issue 2, p174
Academic Journal
No abstract available.


Related Articles

  • Investigating Neurocognitive Features of Hepatitis C Virus Infection in Drug Users: Potential Challenges and Lessons Learned from the HIV Literature. Gonzalez, Raul; Jacobus, Joanna; Martin, Eileen M. // Clinical Infectious Diseases;7/1/2005 Supplement, Vol. 41, pS45 

    Studies of neuro cognition in drug users with hepatitis C virus (HCV) infection are urgently needed but face many challenges. We review similarities between human immunodeficiency virus (H IV) and HCV infection in their neurocognitive features, discuss challenges associated with research among...

  • Parvovirus 4 Infection and Clinical Outcome in High-Risk Populations. Simmons, Ruth; Sharp, Colin; McClure, C. Patrick; Rohrbach, Janine; Kovari, Helen; Frangou, Eleni; Simmonds, Peter; Irving, Will; Rauch, Andri; Bowness, Paul; Klenerman, Paul // Journal of Infectious Diseases;Jun2012, Vol. 205 Issue 12, p1816 

    Parvovirus 4 (PARV4) is a DNA virus frequently associated with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) infections, but its clinical significance is unknown. We studied the prevalence of PARV4 antibodies in 2 cohorts of HIV- and HCV-infected individuals (n = 469) and the...

  • Drug-related harms and responses.  // Drugnet Europe;Oct-Dec2014, Issue 88, p2 

    Information about the meetings on drug overdose and hepatitis C virus (HCV) and human immunodeficiency virus (HIV) infections among drug users held on October 15-17, 2014 is presented.

  • Hepatitis C Transmission in Injection Drug Users: Could Swabs Be the Main Culprit? Thibault, Vincent; Bara, Jean-Louis; Nefau, Thomas; Duplessy-Garson, Catherine // Journal of Infectious Diseases;12/15/2011, Vol. 204 Issue 12, p1839 

    Prevention programs for intravenous drug users have proven their efficacy in decreasing human immunodeficiency virus transmission but have limited effect on hepatitis C virus (HCV) contamination. A study was conducted to document the presence of HCV genome (HCV RNA) in 620 items of used...

  • Human Parvovirus 4 Infection, Cameroon. Lavoie, Myriam; Sharp, Colin P.; Pépin, Jacques; Pennington, Christopher; Foupouapouognigni, Yacouba; Pybus, Oliver G.; Njouom, Richard; Simmonds, Peter // Emerging Infectious Diseases;Apr2012, Vol. 18 Issue 4, p680 

    The article discusses a study that determined the seroprevalence of human parvovirus 4 (PARV4) in the elderly in Ebolowa, Cameroon, among whom prevalence of hepatitis C virus (HCV) infection was high. PARV4 is also known as partetravirus and was identified in 2005 from the plasma of an...

  • Hepatitis C virus and HIV type 1 co-infection. Gupta, Priyanka // Infectious Disease Reports;2013, Vol. 5 Issue 1s, p31 

    Around 33 million people worldwide are living with Human Immunodeficiency Virus (HIV) infection, and approximately 20-30% of HIV-infected individuals are also infected with Hepatitis C virus (HCV). The main form of HCV transmission is via the blood borne route; high rates of co-infection are...

  • Hepatitis C Virus Infection Among non-IDU HIV-Infected and Uninfected Men who Have Sex with Men. Giuliani, Massimo; Nosotti, Lorenzo; Latini, Alessandra; Mirisola, Concetta; Pimpinelli, Fulvia; Volpi, Sabrina; Ensoli, Fabrizio; Impara, Gianpaolo; Palamara, Guido // Mediterranean Journal of Hematology & Infectious Diseases;2011, Vol. 3 Issue 1, p1 

    A letter to the editor is presented which discusses a study on the seroprevalence of chronic hepatitis C virus (HCV) among non-intravenous drug users (IDU) HIV-infected and uninfected men who have sex with men.

  • THE ALIVE STUDY: A LONGITUDINAL STUDY OF HIV-1 INFECTION IN INTRAVENOUS DRUG USERS: DESCRIPTION OF METHODS. Vlahov, David; Anthony, James C.; Mu�oz, Alvaro; Margolick, Joseph; Nelson, Kenrad E.; Celentano, David D.; Solomon, Liza; Polk, B. Frank // Journal of Drug Issues;Fall91, Vol. 21 Issue 4, p759 

    To identify risk factors for infection with the human immunodeficiency virus (HIV) and for progression to the acquired immunodeficiency syndrome (AIDS) among intravenous drug users, we established a cohort in Baltimore Maryland in 1988-1989. Intravenous drug users were recruited by extensive...

  • Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in central China. Chen, Xi; He, Jian-Mei; Ding, Li-Sha; Zhang, Guo-Qiang; Zou, Xiao-Bai; Zheng, Jun // Archives of Virology;Sep2013, Vol. 158 Issue 9, p1889 

    Co-infection of hepatitis B virus (HBV) and/or hepatitis C virus (HCV) with human immunodeficiency virus (HIV) has an adverse effect on liver disease progression. This study investigated the prevalence of HBV and/or HCV co-infection in HIV-infected patients in Central China. A total of 978...

  • Identification of Variants of Hepatitis C Virus (HCV) Entry Factors in Patients Highly Exposed to HCV but Remaining Uninfected: An ANRS Case-Control Study. Fouquet, Baptiste; Ghosn, Jade; Quertainmont, Yann; Salmon, Dominique; Rioux, Christophe; Duvivier, Claudine; Delfraissy, Jean-François; Misrahi, Micheline // PLoS ONE;11/16/2015, Vol. 10 Issue 11, p1 

    Hepatitis C virus (HCV) causes persistent infection in 75% of cases and is a major public health problem worldwide. More than 92% of intravenous drug users (IDU) infected by human immunodeficiency virus type 1 (HIV-1) are seropositive for HCV, and it is conceivable that some HIV-1-infected IDU...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics